| 8 | CNCOpen CNC on Seeking Alpha in a new tab.89% of the way from the 52-week low to the 52-week high. | CenteneHealthcare·Medical - Healthcare Plans | 99 | B Quality: 87th percentile | A Momentum: 90th percentile | C Growth: 54th percentile | B Valuation: 83rd percentile | A Expectations: 98th percentile | QQualityB Quality: 87th percentileMMomentumA Momentum: 90th percentileGGrowthC Growth: 54th percentileVValuationB Valuation: 83rd percentileEExpectationsA Expectations: 98th percentile |
| 23 | THCOpen THC on Seeking Alpha in a new tab.89% of the way from the 52-week low to the 52-week high. | Tenet HealthcareHealthcare·Medical - Care Facilities | 97 | C Quality: 67th percentile | A Momentum: 90th percentile | B Growth: 82nd percentile | A Valuation: 92nd percentile | A Expectations: 94th percentile | QQualityC Quality: 67th percentileMMomentumA Momentum: 90th percentileGGrowthB Growth: 82nd percentileVValuationA Valuation: 92nd percentileEExpectationsA Expectations: 94th percentile |
| 30 | HUMOpen HUM on Seeking Alpha in a new tab.87% of the way from the 52-week low to the 52-week high. | HumanaHealthcare·Medical - Healthcare Plans | 96 | A Quality: 93rd percentile | A Momentum: 96th percentile | E Growth: 9th percentile | B Valuation: 76th percentile | C Expectations: 44th percentile | QQualityA Quality: 93rd percentileMMomentumA Momentum: 96th percentileGGrowthE Growth: 9th percentileVValuationB Valuation: 76th percentileEExpectationsC Expectations: 44th percentile |
| 43 | SOLVOpen SOLV on Seeking Alpha in a new tab.74% of the way from the 52-week low to the 52-week high. | SolventumHealthcare·Medical - Instruments & Supplies | 94 | C Quality: 53rd percentile | B Momentum: 87th percentile | A Growth: 91st percentile | C Valuation: 65th percentile | A Expectations: 91st percentile | QQualityC Quality: 53rd percentileMMomentumB Momentum: 87th percentileGGrowthA Growth: 91st percentileVValuationC Valuation: 65th percentileEExpectationsA Expectations: 91st percentile |
| 46 | ELVOpen ELV on Seeking Alpha in a new tab.89% of the way from the 52-week low to the 52-week high. | Elevance HealthHealthcare·Medical - Healthcare Plans | 94 | A Quality: 93rd percentile | B Momentum: 72nd percentile | E Growth: 9th percentile | A Valuation: 95th percentile | A Expectations: 94th percentile | QQualityA Quality: 93rd percentileMMomentumB Momentum: 72nd percentileGGrowthE Growth: 9th percentileVValuationA Valuation: 95th percentileEExpectationsA Expectations: 94th percentile |
| Top 10% | DXCMOpen DXCM on Seeking Alpha in a new tab.64% of the way from the 52-week low to the 52-week high. | DexComHealthcare·Medical - Devices | 93 | B Quality: 82nd percentile | A Momentum: 90th percentile | B Growth: 86th percentile | C Valuation: 39th percentile | B Expectations: 76th percentile | QQualityB Quality: 82nd percentileMMomentumA Momentum: 90th percentileGGrowthB Growth: 86th percentileVValuationC Valuation: 39th percentileEExpectationsB Expectations: 76th percentile |
| Top 10% | NBIXOpen NBIX on Seeking Alpha in a new tab.37% of the way from the 52-week low to the 52-week high. | Neurocrine BiosciencesHealthcare·Biotechnology | 92 | B Quality: 72nd percentile | C Momentum: 66th percentile | B Growth: 86th percentile | C Valuation: 64th percentile | A Expectations: 95th percentile | QQualityB Quality: 72nd percentileMMomentumC Momentum: 66th percentileGGrowthB Growth: 86th percentileVValuationC Valuation: 64th percentileEExpectationsA Expectations: 95th percentile |
| Top 10% | VTRSOpen VTRS on Seeking Alpha in a new tab.95% of the way from the 52-week low to the 52-week high. | ViatrisHealthcare·Drug Manufacturers - Specialty & Generic | 90 | C Quality: 67th percentile | B Momentum: 83rd percentile | B Growth: 83rd percentile | B Valuation: 79th percentile | B Expectations: 76th percentile | QQualityC Quality: 67th percentileMMomentumB Momentum: 83rd percentileGGrowthB Growth: 83rd percentileVValuationB Valuation: 79th percentileEExpectationsB Expectations: 76th percentile |
| Top 20% | CVSOpen CVS on Seeking Alpha in a new tab.60% of the way from the 52-week low to the 52-week high. | CVS HealthHealthcare·Medical - Healthcare Plans | 90 | B Quality: 71st percentile | B Momentum: 74th percentile | C Growth: 43rd percentile | A Valuation: 95th percentile | A Expectations: 92nd percentile | QQualityB Quality: 71st percentileMMomentumB Momentum: 74th percentileGGrowthC Growth: 43rd percentileVValuationA Valuation: 95th percentileEExpectationsA Expectations: 92nd percentile |
| Top 20% | EXELOpen EXEL on Seeking Alpha in a new tab.98% of the way from the 52-week low to the 52-week high. | ExelixisHealthcare·Biotechnology | 89 | A Quality: 96th percentile | B Momentum: 88th percentile | D Growth: 25th percentile | C Valuation: 56th percentile | C Expectations: 55th percentile | QQualityA Quality: 96th percentileMMomentumB Momentum: 88th percentileGGrowthD Growth: 25th percentileVValuationC Valuation: 56th percentileEExpectationsC Expectations: 55th percentile |
| Top 20% | TECHOpen TECH on Seeking Alpha in a new tab.100% of the way from the 52-week low to the 52-week high. | Bio-TechneHealthcare·Biotechnology | 88 | B Quality: 86th percentile | B Momentum: 88th percentile | A Growth: 92nd percentile | D Valuation: 17th percentile | D Expectations: 16th percentile | QQualityB Quality: 86th percentileMMomentumB Momentum: 88th percentileGGrowthA Growth: 92nd percentileVValuationD Valuation: 17th percentileEExpectationsD Expectations: 16th percentile |
| Top 20% | CIOpen CI on Seeking Alpha in a new tab.87% of the way from the 52-week low to the 52-week high. | CignaHealthcare·Medical - Healthcare Plans | 88 | B Quality: 78th percentile | C Momentum: 40th percentile | B Growth: 72nd percentile | A Valuation: 98th percentile | D Expectations: 28th percentile | QQualityB Quality: 78th percentileMMomentumC Momentum: 40th percentileGGrowthB Growth: 72nd percentileVValuationA Valuation: 98th percentileEExpectationsD Expectations: 28th percentile |
| Top 20% | NTRAOpen NTRA on Seeking Alpha in a new tab.87% of the way from the 52-week low to the 52-week high. | NateraHealthcare·Medical - Diagnostics & Research | 86 | A Quality: 95th percentile | A Momentum: 98th percentile | D Growth: 15th percentile | E Valuation: 3rd percentile | C Expectations: 45th percentile | QQualityA Quality: 95th percentileMMomentumA Momentum: 98th percentileGGrowthD Growth: 15th percentileVValuationE Valuation: 3rd percentileEExpectationsC Expectations: 45th percentile |
| Top 20% | LLYOpen LLY on Seeking Alpha in a new tab.92% of the way from the 52-week low to the 52-week high. | Eli Lilly and CompanyHealthcare·Drug Manufacturers - General | 86 | C Quality: 66th percentile | B Momentum: 89th percentile | A Growth: 93rd percentile | E Valuation: 7th percentile | A Expectations: 90th percentile | QQualityC Quality: 66th percentileMMomentumB Momentum: 89th percentileGGrowthA Growth: 93rd percentileVValuationE Valuation: 7th percentileEExpectationsA Expectations: 90th percentile |
| Top 20% | COROpen COR on Seeking Alpha in a new tab.66% of the way from the 52-week low to the 52-week high. | CencoraHealthcare·Medical - Distribution | 84 | B Quality: 89th percentile | C Momentum: 45th percentile | B Growth: 79th percentile | C Valuation: 64th percentile | C Expectations: 33rd percentile | QQualityB Quality: 89th percentileMMomentumC Momentum: 45th percentileGGrowthB Growth: 79th percentileVValuationC Valuation: 64th percentileEExpectationsC Expectations: 33rd percentile |
| Top 20% | ALNYOpen ALNY on Seeking Alpha in a new tab.10% of the way from the 52-week low to the 52-week high. | Alnylam PharmaceuticalsHealthcare·Biotechnology | 84 | A Quality: 96th percentile | D Momentum: 12th percentile | A Growth: 97th percentile | D Valuation: 21st percentile | E Expectations: 3rd percentile | QQualityA Quality: 96th percentileMMomentumD Momentum: 12th percentileGGrowthA Growth: 97th percentileVValuationD Valuation: 21st percentileEExpectationsE Expectations: 3rd percentile |
| Top 20% | DVAOpen DVA on Seeking Alpha in a new tab.57% of the way from the 52-week low to the 52-week high. | DaVitaHealthcare·Medical - Care Facilities | 83 | –No data | B Momentum: 79th percentile | C Growth: 40th percentile | A Valuation: 97th percentile | C Expectations: 37th percentile | QQuality–No dataMMomentumB Momentum: 79th percentileGGrowthC Growth: 40th percentileVValuationA Valuation: 97th percentileEExpectationsC Expectations: 37th percentile |
| Top 20% | ELANOpen ELAN on Seeking Alpha in a new tab.41% of the way from the 52-week low to the 52-week high. | Elanco Animal HealthHealthcare·Drug Manufacturers - Specialty & Generic | 82 | C Quality: 61st percentile | C Momentum: 48th percentile | B Growth: 89th percentile | C Valuation: 59th percentile | B Expectations: 89th percentile | QQualityC Quality: 61st percentileMMomentumC Momentum: 48th percentileGGrowthB Growth: 89th percentileVValuationC Valuation: 59th percentileEExpectationsB Expectations: 89th percentile |
| Top 20% | TEMOpen TEM on Seeking Alpha in a new tab.50% of the way from the 52-week low to the 52-week high. | Tempus AIHealthcare·Medical - Healthcare Information Services | 82 | B Quality: 85th percentile | A Momentum: 93rd percentile | E Growth: 8th percentile | E Valuation: 4th percentile | A Expectations: 96th percentile | QQualityB Quality: 85th percentileMMomentumA Momentum: 93rd percentileGGrowthE Growth: 8th percentileVValuationE Valuation: 4th percentileEExpectationsA Expectations: 96th percentile |
| Top 20% | INCYOpen INCY on Seeking Alpha in a new tab.60% of the way from the 52-week low to the 52-week high. | IncyteHealthcare·Biotechnology | 81 | C Quality: 62nd percentile | B Momentum: 87th percentile | E Growth: 8th percentile | B Valuation: 82nd percentile | A Expectations: 94th percentile | QQualityC Quality: 62nd percentileMMomentumB Momentum: 87th percentileGGrowthE Growth: 8th percentileVValuationB Valuation: 82nd percentileEExpectationsA Expectations: 94th percentile |
| Top 30% | UHSOpen UHS on Seeking Alpha in a new tab.43% of the way from the 52-week low to the 52-week high. | Universal Health ServicesHealthcare·Medical - Care Facilities | 79 | C Quality: 67th percentile | C Momentum: 46th percentile | C Growth: 39th percentile | A Valuation: 98th percentile | D Expectations: 19th percentile | QQualityC Quality: 67th percentileMMomentumC Momentum: 46th percentileGGrowthC Growth: 39th percentileVValuationA Valuation: 98th percentileEExpectationsD Expectations: 19th percentile |
| Top 30% | HALOOpen HALO on Seeking Alpha in a new tab.100% of the way from the 52-week low to the 52-week high. | Halozyme TherapeuticsHealthcare·Biotechnology | 78 | D Quality: 27th percentile | A Momentum: 96th percentile | C Growth: 49th percentile | D Valuation: 26th percentile | B Expectations: 89th percentile | QQualityD Quality: 27th percentileMMomentumA Momentum: 96th percentileGGrowthC Growth: 49th percentileVValuationD Valuation: 26th percentileEExpectationsB Expectations: 89th percentile |
| Top 30% | CAHOpen CAH on Seeking Alpha in a new tab.92% of the way from the 52-week low to the 52-week high. | Cardinal HealthHealthcare·Medical - Distribution | 77 | –No data | C Momentum: 67th percentile | C Growth: 34th percentile | A Valuation: 91st percentile | B Expectations: 83rd percentile | QQuality–No dataMMomentumC Momentum: 67th percentileGGrowthC Growth: 34th percentileVValuationA Valuation: 91st percentileEExpectationsB Expectations: 83rd percentile |
| Top 30% | BAXOpen BAX on Seeking Alpha in a new tab.67% of the way from the 52-week low to the 52-week high. | Baxter InternationalHealthcare·Medical - Instruments & Supplies | 76 | C Quality: 34th percentile | B Momentum: 86th percentile | D Growth: 28th percentile | C Valuation: 65th percentile | A Expectations: 95th percentile | QQualityC Quality: 34th percentileMMomentumB Momentum: 86th percentileGGrowthD Growth: 28th percentileVValuationC Valuation: 65th percentileEExpectationsA Expectations: 95th percentile |
| Top 30% | BTSGOpen BTSG on Seeking Alpha in a new tab.66% of the way from the 52-week low to the 52-week high. | BrightSpring Health ServicesHealthcare·Medical - Healthcare Information Services | 76 | A Quality: 99th percentile | B Momentum: 77th percentile | E Growth: 0th percentile | C Valuation: 50th percentile | B Expectations: 74th percentile | QQualityA Quality: 99th percentileMMomentumB Momentum: 77th percentileGGrowthE Growth: 0th percentileVValuationC Valuation: 50th percentileEExpectationsB Expectations: 74th percentile |
| Top 30% | INSMOpen INSM on Seeking Alpha in a new tab.2% of the way from the 52-week low to the 52-week high. | InsmedHealthcare·Biotechnology | 73 | D Quality: 20th percentile | D Momentum: 18th percentile | A Growth: 98th percentile | E Valuation: 1st percentile | A Expectations: 97th percentile | QQualityD Quality: 20th percentileMMomentumD Momentum: 18th percentileGGrowthA Growth: 98th percentileVValuationE Valuation: 1st percentileEExpectationsA Expectations: 97th percentile |
| Top 30% | RVTYOpen RVTY on Seeking Alpha in a new tab.93% of the way from the 52-week low to the 52-week high. | RevvityHealthcare·Medical - Diagnostics & Research | 73 | D Quality: 29th percentile | A Momentum: 95th percentile | D Growth: 14th percentile | C Valuation: 39th percentile | B Expectations: 79th percentile | QQualityD Quality: 29th percentileMMomentumA Momentum: 95th percentileGGrowthD Growth: 14th percentileVValuationC Valuation: 39th percentileEExpectationsB Expectations: 79th percentile |
| Top 30% | IQVOpen IQV on Seeking Alpha in a new tab.93% of the way from the 52-week low to the 52-week high. | IQVIAHealthcare·Medical - Diagnostics & Research | 72 | D Quality: 24th percentile | A Momentum: 94th percentile | C Growth: 34th percentile | C Valuation: 49th percentile | C Expectations: 39th percentile | QQualityD Quality: 24th percentileMMomentumA Momentum: 94th percentileGGrowthC Growth: 34th percentileVValuationC Valuation: 49th percentileEExpectationsC Expectations: 39th percentile |
| Top 30% | BMYOpen BMY on Seeking Alpha in a new tab.77% of the way from the 52-week low to the 52-week high. | Bristol-Myers SquibbHealthcare·Drug Manufacturers - General | 72 | C Quality: 57th percentile | C Momentum: 68th percentile | D Growth: 23rd percentile | B Valuation: 82nd percentile | B Expectations: 89th percentile | QQualityC Quality: 57th percentileMMomentumC Momentum: 68th percentileGGrowthD Growth: 23rd percentileVValuationB Valuation: 82nd percentileEExpectationsB Expectations: 89th percentile |
| Top 30% | AVTROpen AVTR on Seeking Alpha in a new tab.98% of the way from the 52-week low to the 52-week high. | AvantorHealthcare·Medical - Instruments & Supplies | 71 | D Quality: 20th percentile | A Momentum: 97th percentile | E Growth: 6th percentile | C Valuation: 52nd percentile | C Expectations: 65th percentile | QQualityD Quality: 20th percentileMMomentumA Momentum: 97th percentileGGrowthE Growth: 6th percentileVValuationC Valuation: 52nd percentileEExpectationsC Expectations: 65th percentile |
| Top 30% | GHOpen GH on Seeking Alpha in a new tab.86% of the way from the 52-week low to the 52-week high. | Guardant HealthHealthcare·Medical - Diagnostics & Research | 70 | –No data | A Momentum: 97th percentile | B Growth: 75th percentile | E Valuation: 2nd percentile | E Expectations: 4th percentile | QQuality–No dataMMomentumA Momentum: 97th percentileGGrowthB Growth: 75th percentileVValuationE Valuation: 2nd percentileEExpectationsE Expectations: 4th percentile |
| Top 40% | MOHOpen MOH on Seeking Alpha in a new tab.68% of the way from the 52-week low to the 52-week high. | Molina HealthcareHealthcare·Medical - Healthcare Plans | 70 | B Quality: 89th percentile | C Momentum: 62nd percentile | D Growth: 15th percentile | C Valuation: 51st percentile | B Expectations: 73rd percentile | QQualityB Quality: 89th percentileMMomentumC Momentum: 62nd percentileGGrowthD Growth: 15th percentileVValuationC Valuation: 51st percentileEExpectationsB Expectations: 73rd percentile |
| Top 40% | MCKOpen MCK on Seeking Alpha in a new tab.88% of the way from the 52-week low to the 52-week high. | McKessonHealthcare·Medical - Distribution | 67 | –No data | C Momentum: 59th percentile | C Growth: 41st percentile | B Valuation: 88th percentile | C Expectations: 39th percentile | QQuality–No dataMMomentumC Momentum: 59th percentileGGrowthC Growth: 41st percentileVValuationB Valuation: 88th percentileEExpectationsC Expectations: 39th percentile |
| Top 40% | LHOpen LH on Seeking Alpha in a new tab.89% of the way from the 52-week low to the 52-week high. | LabcorpHealthcare·Medical - Diagnostics & Research | 67 | C Quality: 65th percentile | B Momentum: 78th percentile | D Growth: 23rd percentile | C Valuation: 66th percentile | C Expectations: 42nd percentile | QQualityC Quality: 65th percentileMMomentumB Momentum: 78th percentileGGrowthD Growth: 23rd percentileVValuationC Valuation: 66th percentileEExpectationsC Expectations: 42nd percentile |
| Top 40% | DGXOpen DGX on Seeking Alpha in a new tab.94% of the way from the 52-week low to the 52-week high. | Quest DiagnosticsHealthcare·Medical - Diagnostics & Research | 67 | C Quality: 53rd percentile | B Momentum: 81st percentile | C Growth: 31st percentile | B Valuation: 72nd percentile | C Expectations: 43rd percentile | QQualityC Quality: 53rd percentileMMomentumB Momentum: 81st percentileGGrowthC Growth: 31st percentileVValuationB Valuation: 72nd percentileEExpectationsC Expectations: 43rd percentile |
| Top 40% | GMEDOpen GMED on Seeking Alpha in a new tab.53% of the way from the 52-week low to the 52-week high. | Globus MedicalHealthcare·Medical - Devices | 67 | B Quality: 88th percentile | E Momentum: 8th percentile | D Growth: 11th percentile | B Valuation: 85th percentile | B Expectations: 85th percentile | QQualityB Quality: 88th percentileMMomentumE Momentum: 8th percentileGGrowthD Growth: 11th percentileVValuationB Valuation: 85th percentileEExpectationsB Expectations: 85th percentile |
| Top 40% | UNHOpen UNH on Seeking Alpha in a new tab.77% of the way from the 52-week low to the 52-week high. | UnitedHealth GroupHealthcare·Medical - Healthcare Plans | 66 | –No data | C Momentum: 64th percentile | D Growth: 27th percentile | B Valuation: 84th percentile | B Expectations: 74th percentile | QQuality–No dataMMomentumC Momentum: 64th percentileGGrowthD Growth: 27th percentileVValuationB Valuation: 84th percentileEExpectationsB Expectations: 74th percentile |
| Top 40% | ABBVOpen ABBV on Seeking Alpha in a new tab.95% of the way from the 52-week low to the 52-week high. | AbbVieHealthcare·Drug Manufacturers - General | 66 | –No data | B Momentum: 89th percentile | B Growth: 77th percentile | D Valuation: 29th percentile | D Expectations: 22nd percentile | QQuality–No dataMMomentumB Momentum: 89th percentileGGrowthB Growth: 77th percentileVValuationD Valuation: 29th percentileEExpectationsD Expectations: 22nd percentile |
| Top 40% | AOpen A on Seeking Alpha in a new tab.96% of the way from the 52-week low to the 52-week high. | Agilent TechnologiesHealthcare·Medical - Diagnostics & Research | 64 | C Quality: 47th percentile | A Momentum: 92nd percentile | C Growth: 55th percentile | D Valuation: 24th percentile | C Expectations: 62nd percentile | QQualityC Quality: 47th percentileMMomentumA Momentum: 92nd percentileGGrowthC Growth: 55th percentileVValuationD Valuation: 24th percentileEExpectationsC Expectations: 62nd percentile |
| Top 40% | EHCOpen EHC on Seeking Alpha in a new tab.84% of the way from the 52-week low to the 52-week high. | Encompass HealthHealthcare·Medical - Care Facilities | 63 | C Quality: 42nd percentile | B Momentum: 83rd percentile | C Growth: 38th percentile | C Valuation: 64th percentile | C Expectations: 44th percentile | QQualityC Quality: 42nd percentileMMomentumB Momentum: 83rd percentileGGrowthC Growth: 38th percentileVValuationC Valuation: 64th percentileEExpectationsC Expectations: 44th percentile |
| Top 40% | MEDPOpen MEDP on Seeking Alpha in a new tab.98% of the way from the 52-week low to the 52-week high. | MedpaceHealthcare·Medical - Diagnostics & Research | 62 | C Quality: 55th percentile | A Momentum: 91st percentile | C Growth: 48th percentile | D Valuation: 20th percentile | C Expectations: 63rd percentile | QQualityC Quality: 55th percentileMMomentumA Momentum: 91st percentileGGrowthC Growth: 48th percentileVValuationD Valuation: 20th percentileEExpectationsC Expectations: 63rd percentile |
| Top 40% | TMOOpen TMO on Seeking Alpha in a new tab.92% of the way from the 52-week low to the 52-week high. | Thermo Fisher ScientificHealthcare·Medical - Diagnostics & Research | 61 | C Quality: 36th percentile | A Momentum: 91st percentile | C Growth: 57th percentile | C Valuation: 36th percentile | C Expectations: 42nd percentile | QQualityC Quality: 36th percentileMMomentumA Momentum: 91st percentileGGrowthC Growth: 57th percentileVValuationC Valuation: 36th percentileEExpectationsC Expectations: 42nd percentile |
| Top 40% | AMGNOpen AMGN on Seeking Alpha in a new tab.96% of the way from the 52-week low to the 52-week high. | AmgenHealthcare·Drug Manufacturers - General | 60 | C Quality: 60th percentile | B Momentum: 84th percentile | C Growth: 60th percentile | C Valuation: 35th percentile | B Expectations: 71st percentile | QQualityC Quality: 60th percentileMMomentumB Momentum: 84th percentileGGrowthC Growth: 60th percentileVValuationC Valuation: 35th percentileEExpectationsB Expectations: 71st percentile |
| Top 40% | REGNOpen REGN on Seeking Alpha in a new tab.82% of the way from the 52-week low to the 52-week high. | Regeneron PharmaceuticalsHealthcare·Biotechnology | 60 | C Quality: 38th percentile | C Momentum: 61st percentile | C Growth: 38th percentile | C Valuation: 61st percentile | A Expectations: 93rd percentile | QQualityC Quality: 38th percentileMMomentumC Momentum: 61st percentileGGrowthC Growth: 38th percentileVValuationC Valuation: 61st percentileEExpectationsA Expectations: 93rd percentile |
| Top 50% | CRLOpen CRL on Seeking Alpha in a new tab.100% of the way from the 52-week low to the 52-week high. | Charles River Laboratories InternationalHealthcare·Medical - Diagnostics & Research | 59 | C Quality: 32nd percentile | A Momentum: 95th percentile | D Growth: 15th percentile | D Valuation: 22nd percentile | C Expectations: 67th percentile | QQualityC Quality: 32nd percentileMMomentumA Momentum: 95th percentileGGrowthD Growth: 15th percentileVValuationD Valuation: 22nd percentileEExpectationsC Expectations: 67th percentile |
| Top 50% | MDTOpen MDT on Seeking Alpha in a new tab.74% of the way from the 52-week low to the 52-week high. | MedtronicHealthcare·Medical - Devices | 58 | C Quality: 44th percentile | C Momentum: 67th percentile | C Growth: 51st percentile | B Valuation: 70th percentile | C Expectations: 42nd percentile | QQualityC Quality: 44th percentileMMomentumC Momentum: 67th percentileGGrowthC Growth: 51st percentileVValuationB Valuation: 70th percentileEExpectationsC Expectations: 42nd percentile |
| Top 50% | HCAOpen HCA on Seeking Alpha in a new tab.56% of the way from the 52-week low to the 52-week high. | HCA HealthcareHealthcare·Medical - Care Facilities | 57 | –No data | C Momentum: 41st percentile | D Growth: 22nd percentile | A Valuation: 90th percentile | D Expectations: 17th percentile | QQuality–No dataMMomentumC Momentum: 41st percentileGGrowthD Growth: 22nd percentileVValuationA Valuation: 90th percentileEExpectationsD Expectations: 17th percentile |
| Top 50% | WSTOpen WST on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high. | West Pharmaceutical ServicesHealthcare·Medical - Instruments & Supplies | 56 | B Quality: 78th percentile | B Momentum: 83rd percentile | C Growth: 55th percentile | D Valuation: 12th percentile | B Expectations: 75th percentile | QQualityB Quality: 78th percentileMMomentumB Momentum: 83rd percentileGGrowthC Growth: 55th percentileVValuationD Valuation: 12th percentileEExpectationsB Expectations: 75th percentile |
| Top 50% | SYKOpen SYK on Seeking Alpha in a new tab.33% of the way from the 52-week low to the 52-week high. | StrykerHealthcare·Medical - Devices | 55 | B Quality: 74th percentile | D Momentum: 12th percentile | B Growth: 77th percentile | C Valuation: 47th percentile | C Expectations: 50th percentile | QQualityB Quality: 74th percentileMMomentumD Momentum: 12th percentileGGrowthB Growth: 77th percentileVValuationC Valuation: 47th percentileEExpectationsC Expectations: 50th percentile |
| Top 50% | STEOpen STE on Seeking Alpha in a new tab.49% of the way from the 52-week low to the 52-week high. | STERISHealthcare·Medical - Specialties | 51 | C Quality: 65th percentile | C Momentum: 33rd percentile | C Growth: 46th percentile | C Valuation: 58th percentile | C Expectations: 40th percentile | QQualityC Quality: 65th percentileMMomentumC Momentum: 33rd percentileGGrowthC Growth: 46th percentileVValuationC Valuation: 58th percentileEExpectationsC Expectations: 40th percentile |